or nasopharyngeal secretions (4, 11, 12) have permitted laboratory confirmation in up to 70% of cases. Optimal sensitivity, however, is only achieved with paired specimens taken several weeks apart; results on single acute specimens have not been as satisfactory (7, 15, 18, 31, 34) .
Pertussis is an acute disease of the respiratory tract characterized by progressive, repetitive, paroxysmal coughing, mild systemic complaints, and lymphocytosis. The disease, caused by Bordetella pertussis, proceeds through a catarrhal and a paroxysmal phase of 1 to 2 weeks duration each before entering a prolonged convalescent phase. The laboratory diagnosis of pertussis has been problematic owing to the pathogenesis of the infection and the fastidious nature of the causative bacterium. Nasopharyngeal culture has been the standard for laboratory diagnosis, but the test lacks sensitivity, particularly later in the course of the disease (24) . Isolation of B. pertussis can be achieved most consistently in the catarrhal or early paroxysmal phase, often before the diagnosis of pertussis is suspected (22) . Even when positive, culture confirmation is often delayed owing to the slow growth of the bacteria in culture and to overgrowth of normal respiratory flora. Direct immunofluorescence (DFA) with nasopharyngeal secretions can provide rapid laboratory confirmation of pertussis, but the test lacks sensitivity and false-positives are common (2, 18) . Problems with the commercially available reagents, nonspecific fluorescence, and interobserver variability are most often cited as the causes of the unreliability of the test.
Serologic methods have proved to be the most sensitive for the laboratory diagnosis of pertussis. Measurement of antibodies to the whole organism or its virulence factors in serum (1, 14, 17, 18, 23) or nasopharyngeal secretions (4, 11, 12) have permitted laboratory confirmation in up to 70% of cases. Optimal sensitivity, however, is only achieved with paired specimens taken several weeks apart; results on single acute specimens have not been as satisfactory (7, 15, 18, 31, 34) .
Pertussis toxin (PT), a biologically active protein produced by B. pertussis, has been proposed as the primary * Corresponding author.
cause of the harmful effects of pertussis (25) and as an important factor in immunity to whooping cough (29) . Also known as lymphocytosis-promoting factor, histamine-sensitizing factor, and islet-activating factor, PT is a prototypic A-B toxin composed of an enzymatically active A monomer and a B oligomer essential for binding of the toxin to the cell and delivering the A subunit into the ceil. The toxin, which catalyzes the ADP-ribosylation of a membrane-bound GTPbinding regulatory protein (32) , induces a distinctive cytopathic effect in Chinese hamster ovary cells (CHO) (20) . The assay is exquisitely sensitive detecting <1 ng of PT per ml (8, 9) . This cytopathic effect can be neutralized with antibodies of PT and has been used to assess monoclonal antibodies to PT (28) and to measure antitoxin response following whooping cough (13, 33) .
The purpose of the present investigation was to assess the usefulness of the CHO assay for a more rapid diagnosis of pertussis. Direct Specimen collection and processing. Nasopharyngeal aspirate specimens (NPA) submitted for the diagnosis of pertussis were handled as previously described (18) . Briefly, NPA were obtained by syringe aspiration through a fine flexible catheter passed through the nose into the nasopharynx, and a blood sample was obtained by fingerstick. Arrangements were made to collect a 3-week follow-up serum specimen. Blood and the NPA still in the catheter were immediately transported from the outpatient diagnostic laboratory to the microbiology laboratory of the Izaak Walton Killam Hospital for Children. There, serum was separated and stored at -20°C. Secretions were expelled onto duplicate sets of charcoal-horse blood agar plates with (C+) or without (C-) cephalexin (40 ,ug/ml) (27) and onto two clear glass slides for immunofluorescence. NPA remaining in the catheter were then collected by rinsing the catheter with 1 ml of PBS-CAA, and the solution was stored frozen at -70°C. Smears were processed by treatment with aprotinin (4 U/ml) (Sigma Chemical Co., St. Louis, Mo.) and were stored at 4°C until examination (19) . Culture plates were incubated at 36°C in a humid environment; one set was visually examined daily for 7 days for colonies typical of B. pertussis. Colonies with typical morphology were examined by Gram stain, and organisms with characteristic gram-negative morphology were confirmed by agglutination as previously described (18) . The second set of cultures was incubated at 36°C for 3 days, and an early culture wash (ECW) was obtained by flooding each plate (ECW [C+] or ECW [C-]) with 1 ml of PBS-CAA and scraping the agar surface with a glass hockey stick. ECW were stored frozen at -70°C until tested.
Simulated clinical specimens were prepared from NPA obtained from healthy laboratory personnel. Suspensions of B. pertussis or B. parapertussis were inoculated into the NPA obtained from these volunteers and processed as described above. ECW were also prepared from cultures of NPA from patients with normal respiratory flora including streptococci of the viridans group, S. aureus and coagulasenegative staphylococci, Neisseria species, S. pyogenes group A, H. influenza, and S. pneumoniae.
CHO cell cytotoxicity assay. The CHO cell assay was performed by the method of Hewlett et al. (20) . CHO cells (CCL61; American Type Culture Collection, Rockville, Md.) grown to confluence were trypsinized and diluted to 3 x 104 cells per ml in F-12 medium (Flow Laboratories, Mississauga, Ontario, Canada) supplemented with 10% fetal calf serum, 0.05% mercaptoethanol, and 1% penicillin and streptomycin (Sigma), and 250-,ul samples were added to each well of a polystyrene microdilution plate (Nunc, Roskilde, Denmark). After 18 to 24 h at 37°C to permit cell attachment to the plates, 50 ,ul of the material to be tested was added to triplicate wells. NPA and ECW were first centrifuged at 8,800 x g for 15 min, heat inactivated at 56°C for 40 min, and recentrifuged for 15 min. PT purified by the method of Sekura et al. (30) was used as a positive control; PBS served as a negative control. For neutralization studies, equal volumes of the test material and a monoclonal antibody to the S1 subunit of PT were mixed at 22°C for 30 min, and 50 ,ul was added to the microdilution wells. After 20 h of incubation at 37°C in a C02 incubator, the culture medium was removed and the cells were fixed with methanol and stained with 2.5% Giemsa stain for 20 min. The plates were coded and read by a single observer who was unaware of the culture results. Cytotoxicity was scored as 0, ±, 1+, or 2+; values of 1+ or 2+ were considered positive. The assay was able to detect 750 pg of PT per ml.
Immunofluorescence and serology. Direct smears of NPA were examined as previously described (18 (Fig. 1C) , B. parapertussis (Fig. 1D) , or other microorganisms commonly found in the upper respiratory tract (Table 1) .
The sensitivity of the CHO assay was related to the number of bacteria present in the original specimen and the duration of bacterial growth before culture harvest. After 24 h of incubation, the CHO assay was unable to detect as many as 24 colonies (Table 2 ). However, after 48 and 72 h of incubation, an original inoculum of 9 to 14 and 2 bacteria (respectively) were all that were necessary for a positive reaction. Bacterial colonies were not visible when the cultures were harvested at 24 or 48 h; in heavily inoculated cultures, bacterial growth was faintly visible by 72 h. Serial dilutions were performed on the 48-h harvests to determine the number of bacteria present in 2, 9, or 24 colonies. These 48-h cultures contained 1 with NPA (P = 0.003). CHO with ECW from culture medium containing cephalexin was superior to routine charcoal blood agar. All culture-positive specimens positive by CHO with NPA were also positive by CHO with ECW. All culture-positive specimens positive by CHO with ECW from medium without cephalexin were also positive from medium with cephalexin.
DFA was significantly less specific than either CHO with NPA (P = 0.04) or CHO with ECW (P = 0.04) ( Table 3) . DFA had a lower positive predictive value than CHO with either NPA (P = 0.02) or ECW (P < 0.001) and a lower negative predictive value than CHO with ECW (P < 0.001).
Paired serum specimens were available from 71% of patients with a positive test for pertussis. In 11 (52%) of 21 DFA-positive patients in whom paired sera were available, there was serologic evidence of pertussis by enzyme immunoassay. This was significantly less frequent than patients positive by NPA culture (33 Using nasopharyngeal culture as the "gold standard," there were 13 "false-positive" specimens by DFA and 5 by (6) and verotoxin produced by E. coli 0157 in cases of hemolytic uremic syndrome (21) . The exquisite sensitivity of CHO cell monolayers to PT and the distinctness of the morphologic changes produced make the CHO assay an attractive candidate for use as a pertussis diagnostic test. This study demonstrated that the CHO assay can be used to detect PT both in nasopharyngeal secretions and in early harvests of nasopharyngeal cultures.
The development of a rapid and reliable test for the laboratory diagnosis of pertussis has remained elusive. Nasopharyngeal culture, the standard by which all tests are judged owing to its absolute specificity, is slow and insensitive (24) . DFA is the most frequently used rapid diagnostic test but also lacks sensitivity (2, 18) . The specificity of DFA is also questioned; false-positive rates as high as 40% have been reported, presumably because of inadequate reagents, interobserver unreliability, and autofluorescence of respiratory tract mucus (2, 5, 10, 18) .
CHO cell monolayers are sensitive to picogram quantities of PT (8, 9, 20) . Using pure cultures, we demonstrated that sufficient PT is produced after 48 h by two colonies of B. pertussis, containing 1.6 x 106 CFU/ml, to induce morphologic changes in CHO cells. This effect was specific for B. pertussis; no cytopathic effect was induced by respiratory secretions or other respiratory tract microorganisms, nor did the presence of other organisms interfere with the cytotoxic effect produced by B. pertussis in mixed culture. The data also showed, for the first time, that sufficient free PT is present in the nasopharynx of patients with pertussis to induce the morphologic changes in CHO cells.
VOL. 28, 1990 on October 19, 2017 by guest http://jcm.asm.org/ Downloaded from The CHO assay proved superior to DFA in both ease of performance and interpretation. Specimen preparation only required heat sterilization and clarification by centrifugation. Filter sterilization, which would have been much quicker, caused unacceptable loss of sensitivity owing to binding of PT by the filters (data not shown). Difficulties with test interpretation were considerably less common with the CHO assay because the presence of small quantities of PT give rise to a full morphologic response in the CHO monolayer. The morphologic changes that occur are readily distinguishable from those caused by other toxins or nonspecific cellular damage (20) and were always neutralized by PT antibody. The CHO assay was also preferable to DFA because of its better sensitivity, specificity, and positive and negative predictive values. False-positives were more common with DFA and were less likely to be confirmed as true positives by serologic methods. In contrast, "false-positives" in the CHO assay were all derived from patients who had positive pertussis serology and CHO neutralization.
The use of the CHO assay in conjunction with nasopharyngeal culture reduced by 43% the delay in laboratory diagnosis of pertussis. The data obtained with pure cultures and simulated clinical specimens suggest that further reduction might be possible by harvesting cultures after 2 days; however, the effect on sensitivity will need to be examined. The CHO assay was unable to substitute for culture without significant loss of sensitivity; however, the use of both tests increased the number of laboratory-confirmed cases. The lower sensitivity of the CHO assay on NPA relative to culture may be related to the quality of the specimens available since material used for CHO was considerably more dilute than material used for culture. Catheters containing nasopharyngeal secretions were inoculated onto media for standard culture, then slides for DFA, then onto duplicate cultures, and finally rinsed with PBS-CAA. Thus, cultures used for ECW were secondary inoculations, and the CHO assay with NPA was performed on a rinse after all other procedures had been performed. The 75 and 45% sensitivities of the CHO assay on ECW and NPA, respectively, likely represent the minimum sensitivities of these assays.
One disadvantage of the CHO assay as a rapid diagnostic test is that, like DFA, bacteria must be present in the nasopharynx. PT is an extracellular protein produced by virulent strains of B. pertussis (25) that binds to target cells by its B oligomer, allowing the enzymatically active A unit to exert its effect through ADP-ribosylation (32) . Once bound, the toxin is unlikely to be detectable in secretions by the CHO assay, which requires the presence of the holotoxin (3). After clearance of the bacteria from the nasopharynx, the CHO assay is unlikely to aid in establishing the diagnosis. One potential advantage of the CHO assay is enabling the diagnosis of cases of pertussis that are culture negative, despite the presence of bacteria in the nasopharynx. This situation may occur because of previous immunization or antibiotic therapy, overgrowth in culture by normal respiratory flora, or difficulties with bacterial viability caused by specimen collection, transport, or culture (24) . Symptoms characteristic of pertussis do not occur until the paroxysmal phase when the bacteria are less reliably recovered from the nasopharynx. Thus, specimens are often obtained for diagnosis after the organism has been eliminated. The CHO assay, like DFA and culture, depends on the presence of the bacteria and therefore will be useful only early in the clinical course. Other assays, such as enzyme immunoassays that detect antibody against PT or filamentous hemagglutinin in nasopharyngeal secretions, may be of greater benefit later in the course of infection (12) .
The results of this study demonstrated that the CHO cell assay is a sensitive and specific test that can augment both the speed and reliability of the diagnosis of pertussis when used with nasopharyngeal culture. The CHO cell assay is a suitable alternative to DFA for the rapid diagnosis of pertussis. Improved specimen collection for use in the CHO cell assay may permit future substitution of this assay for nasopharyngeal culture, although further comparative studies are required. Diagnostic tests which are not dependent on the presence of the pathogen will be needed for the diagnosis of pertussis later in the course of the illness.
